Guardant Health, Inc. (GH)

USD 46.85

(-4.13%)

Total Liabilities Summary of Guardant Health, Inc.

  • Guardant Health, Inc.'s latest annual total liabilities in 2023 was 1.62 Billion USD , up 5.03% from previous year.
  • Guardant Health, Inc.'s latest quarterly total liabilities in 2024 Q2 was 1.61 Billion USD , down -1.55% from previous quarter.
  • Guardant Health, Inc. reported annual total liabilities of 1.54 Billion USD in 2022, down -0.62% from previous year.
  • Guardant Health, Inc. reported annual total liabilities of 1.55 Billion USD in 2021, up 70.22% from previous year.
  • Guardant Health, Inc. reported quarterly total liabilities of 1.61 Billion USD for 2024 Q2, down -1.55% from previous quarter.
  • Guardant Health, Inc. reported quarterly total liabilities of 1.62 Billion USD for 2023 Q4, up 3.75% from previous quarter.

Annual Total Liabilities Chart of Guardant Health, Inc. (2023 - 2016)

Historical Annual Total Liabilities of Guardant Health, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 1.62 Billion USD 5.03%
2022 1.54 Billion USD -0.62%
2021 1.55 Billion USD 70.22%
2020 916.18 Million USD 699.87%
2019 114.54 Million USD 83.41%
2018 62.45 Million USD 81.9%
2017 34.33 Million USD -6.88%
2016 36.86 Million USD 0.0%

Peer Total Liabilities Comparison of Guardant Health, Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD -3946.48%
Applied DNA Sciences, Inc. 8.77 Million USD -18440.909%
Aspira Women's Health Inc. 8.62 Million USD -18767.938%
Biodesix, Inc. 94.51 Million USD -1622.181%
BioNexus Gene Lab Corp. 1.74 Million USD -93343.865%
bioAffinity Technologies, Inc. 3.36 Million USD -48253.933%
bioAffinity Technologies, Inc. 3.36 Million USD -48253.933%
Bionano Genomics, Inc. 118.24 Million USD -1276.557%
CareDx, Inc 223.28 Million USD -628.989%
Check-Cap Ltd. 1.33 Million USD -122286.241%
Castle Biosciences, Inc. 86.54 Million USD -1780.864%
DarioHealth Corp. 38.24 Million USD -4156.078%
Exact Sciences Corporation 3.32 Billion USD 51.061%
Fulgent Genetics, Inc. 139.82 Million USD -1064.141%
ICON Public Limited Company 7.74 Billion USD 78.995%
IDEXX Laboratories, Inc. 1.77 Billion USD 8.317%
Illumina, Inc. 4.36 Billion USD 62.718%
Intelligent Bio Solutions Inc. 5.59 Million USD -28989.214%
iSpecimen Inc. 6.07 Million USD -26680.535%
Standard BioTools Inc. 159.86 Million USD -918.195%
MDxHealth SA 121.92 Million USD -1235.042%
23andMe Holding Co. 206.64 Million USD -687.69%
Medpace Holdings, Inc. 1.09 Billion USD -48.262%
Myriad Genetics, Inc. 312.9 Million USD -420.21%
Mainz Biomed B.V. 12.15 Million USD -13286.213%
ENDRA Life Sciences Inc. 1.09 Million USD -148530.47%
NeoGenomics, Inc. 739.69 Million USD -120.056%
Neogen Corporation 1.44 Billion USD -13.036%
Inotiv, Inc. 588.04 Million USD -176.807%
Natera, Inc. 691.79 Million USD -135.291%
OPKO Health, Inc. 622.47 Million USD -161.493%
Psychemedics Corporation 6.59 Million USD -24570.158%
Prenetics Global Limited 44.01 Million USD -3598.289%
Prenetics Global Limited 44.01 Million USD -3598.289%
Precipio, Inc. 3.67 Million USD -44228.35%
Personalis, Inc. 95.65 Million USD -1601.621%
RadNet, Inc. 2.07 Billion USD 21.492%
Sera Prognostics, Inc. 25.28 Million USD -6338.069%
Sotera Health Company 2.68 Billion USD 39.415%
Neuronetics, Inc. 81.64 Million USD -1893.774%
Star Equity Holdings, Inc. 21.67 Million USD -7409.744%
Star Equity Holdings, Inc. 21.67 Million USD -7409.744%
Trinity Biotech plc 83.38 Million USD -1852.098%
Twist Bioscience Corporation 152.97 Million USD -964.082%
Exagen Inc. 34.25 Million USD -4652.517%